News by Year - 2018

Infectious Diseases Can Be Tackled, Here are 3 Solutions

Post Date: 
2018-05-09
Source: 
The Hill
The Hill: OpEd by Dr. Bob Bollinger: During epidemics, time is of the essence. Quick delivery of care to sick patients eases the human impact and lowers the cost of disease.

Shah Receives Dr. David Glasser Memorial Award for TB Control in Maryland

Post Date: 
2018-04-27
Dr. Maunank Shah
Award recognizes significant contributions to tuberculosis prevention & control in MD.

Smartphone App Keeps an ‘Eye’ on Daily Tuberculosis Therapy

Post Date: 
2018-04-26
Johns Hopkins Medicine logo
Study shows success with TB therapy observation conducted via video instead of via in-person clinic visits.

World Tuberculosis (TB) Day Recognized with Community Event at BJGMC

Post Date: 
2018-04-17
Community Event at BJGMC in Pune, India
This year's themes: Maintaining healthy nutrition, addressing mental heatlh challenges, and the latest in TB research.

Tornheim Receives W. Leigh Thompson Excellence in Research Award

Post Date: 
2018-03-21
Photo of Dr. Jeffrey Tornheim
Jeff Tornheim's research on drug-resistant tuberculosis in India garners high honors from Johns Hopkins Department of Medicine.

Isoniazid preventive therapy: do the risks outweigh the benefits in pregnant women with HIV?

Post Date: 
2018-03-13
Source: 
aidsmap
. . . Isoniazid preventive therapy (IPT) during and after pregnancy in women living with HIV on antiretroviral therapy (ART) in tuberculosis (TB) endemic areas in Africa, Asia and Haiti resulted in serious adverse events quite possibly attributable to isoniazid with no significant reduction in TB...

Adverse pregnancy outcomes with isoniazid preventive therapy in HIV

Post Date: 
2018-03-09
Source: 
Infectious Disease Advisor
. . . The safety of IPT in pregnant women with HIV is unknown, especially with regard to its combination with highly active antiretroviral therapy (ART). Amita Gupta, MD, deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University...

No difference in safety for HIV+ pregnant women deferring TB Tx

Post Date: 
2018-03-09
Source: 
MedPage Today
First randomized clinical trail of IPT in pregnant and postpartum women may suggest need for WHO guideline change.

Preventive TB therapy during pregnancy causes excessive adverse events

Post Date: 
2018-03-08
Source: 
Healio Infectious Disease News
. . . “Identifying ways to prevent TB during pregnancy and the postpartum period is a really important way to address maternal and infant health for a globally important disease such as tuberculosis,” Amita Gupta, MD, MHS, associate professor of medicine and international health and deputy director...

Study Results for IMPAACT P1078 Presented at CROI 2018

Post Date: 
2018-03-07
Source: 
IMPAACT Network News
IMPAACT Network News: Dr. Amita Gupta presented findings at CROI 2018.

CCGHE at CROI 2018

Post Date: 
2018-03-05
Check out where and when CCGHE presented at the Conference on Retroviruses and Opportunistic Infections. One Month of Rifapentine/Isoniazid to Prevent TB In People With HIV: Brief-TB/A5279 Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz JT, Omoz-Oarhe A, Juste MAJ, Lama JR, Valencia JA,...

One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV

Post Date: 
2018-03-05
National Institutes of Health Logo
The Indo-JHU Clinical Research Partnership participated in this important study that could change TB prevention for people living with HIV.

TB medication adherence rates up, thanks to smartphone app

Post Date: 
2018-03-02
Source: 
YourCentralValley.com (Fresno, CA)
Emocha's app is helping tuberculosis patients in Fresno County stick to their treatment plans.

Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Post Date: 
2018-03-01
Newswise — Amita Gupta, M.D., deputy director of the Johns Hopkins University Center for Clinical Global Health Education at the Johns Hopkins University School of Medicine, will present a multicounty study of preventive treatment for tuberculosis (TB) in HIV-infected pregnant and postpartum women—...

emocha Named to 2018 Top 10 Most Innovative Companies in Health by Fast Company

Post Date: 
2018-02-20
The Most Innovative Companies list recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness.

2017 Year in Review

Post Date: 
2018-02-19
What a year! Our 2017 Year In Review outlines the most ambitious 365 days we’ve had to date.

WHO sets disease priorities for 2018; Tuberculosis once again not included

Post Date: 
2018-02-15
Source: 
Contagion Live: Infectious Diseases Today
CCGHE Director Bob Bollinger weighs in on WHO's priority pathogens for 2018.

Uniting for a Healthier India

Post Date: 
2018-02-14
Uniting India slide
"The Indo-US clinical research & education partnership started with a single NIH grant to study maternal-infant HIV transmission." Now with 76 studies underway, this short film chronicles the history & impact of our work in India.

The Health App that Beat Hurricane Harvey

Post Date: 
2018-01-18
Source: 
Politico
CCGHE invented the emocha Mobile Health platform, and it's changing the way tuberculosis patients are cared for.

In-Depth: How digital health technologies can help the United States address the opioid epidemic

Post Date: 
2018-01-05
Source: 
MobiHealthNews
Bob Bollinger interviewed about utility of mobile health in keeping patients connected to care.